Amenorrhoea Profile Test at Chughtai Lab in Pakistan

Amenorrhoea Profile at Chughtai Lab

The Amenorrhoea Profile at Chughtai Lab is a comprehensive, specialized panel of laboratory investigations designed to evaluate the underlying hormonal and endocrine causes of amenorrhoea—the medical term for the absence of menstruation. Menstruation is a complex physiological process regulated by the precise, coordinated interaction of the hypothalamic-pituitary-ovarian (HPO) axis, the thyroid gland, and the adrenal glands. When any part of this intricate system is disrupted, it can lead to irregular cycles or a complete cessation of periods. This profile serves as an essential diagnostic tool for gynecologists, endocrinologists, and primary care physicians across Pakistan to identify the root cause of menstrual dysfunction and formulate targeted, evidence-based treatment plans.

The profile typically measures key hormones, including Follicle Stimulating Hormone (FSH), Luteinizing Hormone (LH), Prolactin, and Thyroid Stimulating Hormone (TSH). Depending on clinical requirements, it may also evaluate Estradiol and androgen levels. By analyzing these biomarkers, pathologists can pinpoint whether the issue originates in the ovaries (primary ovarian insufficiency), the pituitary gland (hyperprolactinemia or gonadotropin deficiency), the hypothalamus (functional hypothalamic amenorrhoea), or the thyroid gland (hypothyroidism or hyperthyroidism). Understanding these pathways is critical, as amenorrhoea is not a disease in itself but rather a clinical symptom of an underlying systemic, genetic, or endocrine disorder.

Chughtai Lab, a premier diagnostic network in Pakistan, utilizes state-of-the-art fully automated immunoassay analyzers to perform these hormonal assays. This advanced technology ensures maximum sensitivity and specificity, minimizing the risk of analytical errors. For patients, this translates to highly reliable results that form the foundation of successful clinical management, whether the goal is restoring fertility, managing metabolic disorders like Polycystic Ovary Syndrome (PCOS), or preventing long-term complications such as osteoporosis.

Clinical Procedure: What to Expect

Patient Preparation

Proper preparation is critical to ensure the clinical accuracy of hormone levels, as many endocrine markers fluctuate based on diurnal rhythms, stress, and dietary factors. Patients undergoing the Amenorrhoea Profile at Chughtai Lab should adhere to the following guidelines:

• Fasting Requirements: While a strict fast is not always mandatory for all hormones in this profile, a morning sample is highly recommended. It is generally advised to fast for 8 to 12 hours before the blood draw to minimize any dietary interference with metabolic markers.
• Timing of the Test: If the patient experiences occasional, highly irregular periods, the physician may recommend collecting the sample on specific days of the menstrual cycle (typically day 2, 3, or 4). For patients with complete absence of menstruation, the test can be performed on any day.
• Prolactin Stabilization: Prolactin levels are highly sensitive to physical stress, exercise, sleep patterns, and breast stimulation. Patients should rest quietly for 15 to 30 minutes before the blood draw and avoid strenuous exercise or breast stimulation for 24 hours prior to the test.
• Medication Disclosure: Certain medications, including oral contraceptives, thyroid hormones, steroids, antipsychotics, and antidepressants, can significantly alter hormone levels. Patients must inform their physician and the lab staff of all medications and supplements they are currently taking. Do not stop prescribed medications without consulting your doctor.

During the Procedure

The Amenorrhoea Profile is a straightforward laboratory investigation requiring a standard peripheral blood sample. The procedure is conducted by highly trained phlebotomists at Chughtai Lab collection centers or through their convenient home sample collection service:

• Venipuncture: The phlebotomist will locate a suitable vein, typically in the antecubital fossa (the crook of the elbow). The area is thoroughly cleansed with an antiseptic swab to prevent infection.
• Sample Collection: A sterile, single-use needle is inserted into the vein, and blood is drawn into a vacuum tube (usually a serum separator tube or SST). The process is quick, typically taking less than two minutes.
• Patient Experience: Patients may feel a brief pinch or stinging sensation as the needle enters the skin. There is minimal discomfort associated with the blood draw.
• Post-Procedure Care: After removing the needle, pressure is applied to the puncture site with a sterile cotton ball, followed by the application of a bandage. Patients can immediately resume their daily activities.
• Safety and Quality Control: Chughtai Lab adheres to strict international safety protocols. All samples are barcoded at the point of collection to eliminate any risk of sample mix-ups, ensuring absolute traceability from collection to final reporting.

When is an Amenorrhoea Profile Performed?

Investigating Primary Amenorrhoea

Primary amenorrhoea is diagnosed when a young woman has not started her menstrual periods by age 15, in the presence of normal secondary sexual characteristics, or by age 13 if secondary sexual characteristics (such as breast development) are absent. Physicians request the Amenorrhoea Profile in these cases to evaluate the functional integrity of the ovaries and pituitary gland. It helps differentiate between genetic anomalies, such as Turner syndrome (characterized by elevated gonadotropins), and developmental delays or congenital structural abnormalities of the reproductive tract.

Evaluating Secondary Amenorrhoea

Secondary amenorrhoea refers to the absence of menstrual periods for three consecutive months in a woman who previously had regular cycles, or six months in a woman with a history of irregular cycles. This is the most common form of amenorrhoea. The profile is essential to rule out premature ovarian failure, hypothalamic suppression, or pituitary lesions. By evaluating FSH, LH, and Prolactin, clinicians can determine if the cessation of periods is due to ovarian depletion or a central nervous system disruption.

Suspected Polycystic Ovary Syndrome (PCOS)

Polycystic Ovary Syndrome is a highly prevalent endocrine disorder among women of reproductive age in Pakistan. It is characterized by irregular periods, ovulatory dysfunction, and hyperandrogenism. Physicians order this profile to assess the LH to FSH ratio, which is frequently elevated in women with PCOS. Combined with clinical symptoms like hirsutism, acne, and weight gain, the hormonal data from this profile allows for an accurate diagnosis and the initiation of metabolic and lifestyle interventions.

Diagnosing Premature Ovarian Insufficiency (POI)

Premature Ovarian Insufficiency, also known as premature ovarian failure, occurs when the ovaries stop functioning normally before the age of 40. Patients often present with symptoms mimicking menopause, such as hot flashes, night sweats, vaginal dryness, and mood swings. A high level of FSH, coupled with low estradiol levels detected in the Amenorrhoea Profile, confirms the decline in ovarian follicular activity, enabling timely hormone replacement therapy (HRT) to protect bone and cardiovascular health.

Screening for Hyperprolactinemia and Thyroid Disorders

Elevated levels of prolactin (hyperprolactinemia) directly inhibit the pulsatile secretion of Gonadotropin-Releasing Hormone (GnRH) from the hypothalamus, leading to decreased LH and FSH secretion and subsequent amenorrhoea. Similarly, thyroid dysfunction—particularly hypothyroidism—can disrupt menstrual cycles by altering sex hormone-binding globulin (SHBG) levels and prolactin clearance. The inclusion of Prolactin and TSH in this profile allows clinicians to identify pituitary microadenomas or thyroid disease as the primary drivers of menstrual cessation.

What Does an Amenorrhoea Profile Detect?

The Amenorrhoea Profile is a powerful diagnostic panel that can detect a wide spectrum of endocrine, metabolic, and reproductive disorders. By analyzing the synergistic relationships between different hormones, the test can identify:

• Primary Ovarian Insufficiency (POI): Indicated by persistently elevated FSH and LH levels in women under 40, reflecting a depletion of ovarian follicles.
• Hyperprolactinemia: Excessively high levels of prolactin, which may point to a prolactin-secreting pituitary adenoma (prolactinoma), drug-induced elevations, or systemic stress.
• Hypothyroidism: Elevated TSH levels, indicating an underactive thyroid gland which impairs normal ovarian function and alters menstrual regularity.
• Hyperthyroidism: Suppressed TSH levels, indicating an overactive thyroid that can cause light, irregular, or absent periods.
• Polycystic Ovary Syndrome (PCOS): Suggested by an altered LH/FSH ratio (often greater than 2:1 or 3:1) accompanied by elevated androgen levels.
• Functional Hypothalamic Amenorrhoea (FHA): Characterized by low or low-normal FSH, LH, and Estradiol levels, typically caused by chronic stress, excessive exercise, rapid weight loss, or eating disorders.
• Hypogonadotropic Hypogonadism: Low levels of both gonadotropins (FSH and LH) and ovarian steroids, indicating a structural or functional defect in the hypothalamus or pituitary gland (such as Sheehan’s syndrome or pituitary tumors).
• Hypergonadotropic Hypogonadism: High levels of FSH and LH with low estradiol, pointing directly to ovarian failure or gonadal dysgenesis.
• Adrenal Hyperplasia or Androgen-Secreting Tumors: Detected through elevated levels of free or total testosterone, which can cause severe virilization and menstrual arrest.
• Physiological Menopause: Elevated FSH and LH levels in women of appropriate age (typically over 45 to 50 years), confirming the natural transition out of the reproductive years.

Turnaround Time and Report Access at Chughtai Lab

Chughtai Lab is widely recognized across Pakistan for its rapid turnaround times and highly accessible reporting systems. For specialized hormonal assays like the Amenorrhoea Profile, the laboratory utilizes advanced, high-throughput chemiluminescent immunoassay (CLIA) technology, which allows for precise and rapid processing. Most hormone test results are completed and verified by consultant pathologists within 24 to 48 hours of sample collection.

Patients can access their diagnostic reports through multiple convenient digital channels. Once the results are verified, an automated SMS notification containing a direct download link is sent to the patient’s registered mobile number. Reports can also be accessed online via the official Chughtai Lab website by entering the patient ID and case number. Additionally, the “My Chughtai” mobile application, available for both iOS and Android, provides a secure portal where patients can view, download, and archive their entire diagnostic history, facilitating seamless sharing with their consulting physicians.

Amenorrhoea Profile Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Follicle Stimulating Hormone (FSH)	Varies by cycle phase; typically 3.5–12.5 mIU/mL in follicular phase.	Elevated in ovarian failure/menopause; low in hypothalamic or pituitary dysfunction.
Luteinizing Hormone (LH)	Varies by cycle phase; typically 2.4–12.6 mIU/mL in follicular phase.	Elevated in PCOS (high LH/FSH ratio) or ovarian failure; low in hypogonadotropic states.
Prolactin (PRL)	Typically less than 25 ng/mL in non-pregnant females.	Elevated (hyperprolactinemia) due to prolactinoma, medications, or stress; causes ovulatory arrest.
Thyroid Stimulating Hormone (TSH)	Typically 0.4–4.0 mIU/L.	Elevated in primary hypothyroidism; suppressed in hyperthyroidism; both disrupt menses.
Estradiol (E2)	Varies by cycle phase; typically 12.5–166 pg/mL in follicular phase.	Severely decreased in ovarian failure, menopause, or functional hypothalamic amenorrhoea.
Total/Free Testosterone	Typically 15–70 ng/dL (Total).	Elevated in PCOS, congenital adrenal hyperplasia, or androgen-secreting ovarian/adrenal tumors.
Beta-hCG (if indicated)	Negative (less than 5 mIU/mL).	Positive, indicating pregnancy, which is the most common physiological cause of secondary amenorrhoea.

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Chughtai Lab for Amenorrhoea Profile?

• Experienced Healthcare Professionals: Chughtai Lab’s pathology department is led by highly qualified, board-certified consultant pathologists who oversee all hormonal assays.
• Patient-Focused Care: The lab prioritizes patient comfort, offering a compassionate and supportive environment at all collection centers across Pakistan.
• Quality Diagnostic Services: Operating under strict international standards, Chughtai Lab participates in external quality assurance programs to guarantee test accuracy.
• Professional Reporting: Reports are detailed, structured, and include clear reference ranges to assist clinicians in making accurate diagnoses.
• Modern Diagnostic Approach: Utilizing state-of-the-art fully automated immunoassay platforms minimizes human error and ensures highly reproducible results.
• Comfortable Environment: All diagnostic centers are designed to provide a clean, hygienic, and comfortable experience for patients during sample collection.
• Convenient Location: With an extensive network of hundreds of collection centers across major cities like Lahore, Karachi, and Islamabad, access is highly convenient.
• Commitment to Accurate Diagnosis: Chughtai Lab’s dedication to clinical excellence ensures that your Amenorrhoea Profile is processed with the highest level of medical precision.